Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (312K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Miyamoto-Sato, E.
Right arrow Articles by Yanagawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyamoto-Sato, E.
Right arrow Articles by Yanagawa, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2000, Vol. 28, No. 5 1176-1182
© 2000 Oxford University Press

Specific bonding of puromycin to full-length protein at the C-terminus

Etsuko Miyamoto-Sato1,2, Naoto Nemoto1, Kensei Kobayashi2 and Hiroshi Yanagawa1,*

1Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan and 2Department of Chemistry and Biotechnology, Faculty of Engineering, Yokohama National University, Hodogaya-ku, Yokohama 240-8501, Japan

Puromycin, an analog of the 3' end of aminoacyl-tRNA, causes premature termination of translation by being linked non-specifically to growing polypeptide chains. Here we report the interesting phenomenon that puromycin acting as a non-inhibitor at very low concentration (e.g. 0.04 µM) can bond only to full-length protein at the C-terminus. This was proved by using a carboxypeptidase digestion assay of the products obtained by Escherichia coli cell-free translation of human tau 4 repeat (tau4R) mRNA in the presence of low concentrations of puromycin or its derivatives. The tau4R mRNA was modified to code for three C-terminal methionines, which were radioactively labeled, followed by a stop codon. The translation products could not be digested by carboxy-peptidase if puromycin or a derivative was present at the C-terminus of full-length tau4R. Puromycin and its derivatives at 0.04–1.0 µM bonded to 7–21% of full-length tau4R, depending on the ability to act as acceptor substrates. Furthermore, the bonding efficiency of a puromycin derivative to tau4R was decreased by addition of release factors. These results suggest that puromycin and its derivatives at concentrations lower than those able to compete effectively with aminoacyl-tRNA can bond specifically to full-length protein at a stop codon. This specific bonding of puromycin to full-length protein should be useful for in vitro selection of proteins and for in vitro and in vivo C-terminal end protein labeling.

* To whom correspondence should be addressed. Tel: +81 427 24 6293; Fax: +81 427 24 6317; Email: hyana@libra.ls.m-kagaku.co.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J BiochemHome page
Y. Kawahashi, N. Doi, Y. Oishi, C. Tsuda, H. Takashima, T. Baba, H. Mori, T. Ito, and H. Yanagawa
High-throughput Fluorescence Labelling of Full-length cDNA Products Based on a Reconstituted Translation System
J. Biochem., January 1, 2007; 141(1): 19 - 24.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
I. Fukuda, K. Kojoh, N. Tabata, N. Doi, H. Takashima, E. Miyamoto-Sato, and H. Yanagawa
In vitro evolution of single-chain antibodies using mRNA display
Nucleic Acids Res., November 14, 2006; 34(19): e127 - e127.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
Y. Sasuga, T. Tani, M. Hayashi, H. Yamakawa, O. Ohara, and Y. Harada
Development of a microscopic platform for real-time monitoring of biomolecular interactions
Genome Res., January 1, 2006; 16(1): 132 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
E. Miyamoto-Sato, M. Ishizaka, K. Horisawa, S. Tateyama, H. Takashima, S. Fuse, K. Sue, N. Hirai, K. Masuoka, and H. Yanagawa
Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes
Genome Res., May 1, 2005; 15(5): 710 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
K. Horisawa, S. Tateyama, M. Ishizaka, N. Matsumura, H. Takashima, E. Miyamoto-Sato, N. Doi, and H. Yanagawa
In vitro selection of Jun-associated proteins using mRNA display
Nucleic Acids Res., December 2, 2004; 32(21): e169 - e169.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
E. Miyamoto-Sato, H. Takashima, S. Fuse, K. Sue, M. Ishizaka, S. Tateyama, K. Horisawa, T. Sawasaki, Y. Endo, and H. Yanagawa
Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins
Nucleic Acids Res., August 1, 2003; 31(15): e78 - e78.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T. Tsuji, M. Onimaru, and H. Yanagawa
Random multi-recombinant PCR for the construction of combinatorial protein libraries
Nucleic Acids Res., October 15, 2001; 29(20): e97 - e97.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
N. Doi, H. Takashima, M. Kinjo, K. Sakata, Y. Kawahashi, Y. Oishi, R. Oyama, E. Miyamoto-Sato, T. Sawasaki, Y. Endo, et al.
Novel Fluorescence Labeling and High-Throughput Assay Technologies for In Vitro Analysis of Protein Interactions
Genome Res., March 1, 2002; 12(3): 487 - 492.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.